Zymeworks Inc (NYSE:ZYME)
| 30.22 Delayed Data As of 4:00pm ET |  -0.64 / -2.07%Today’s Change | 20.33 Today|||52-Week Range 52.75 | -33.52% Year-to-Date |
Latest ZYME News | Press Releases
No recent news for Zymeworks Inc.
Today’s Trading
| Previous close | 30.86 |
| Today’s open | 30.86 |
| Day’s range | 30.04 - 31.16 |
| Volume | 196,647 |
| Average volume (3 months) | 428,640 |
| Market cap | $1.4B |
Data as of 4:00pm ET, 08/11/2020
Growth & Valuation
| Earnings growth (last year) | -204.38% |
| Earnings growth (this year) | +8.82% |
| Earnings growth (next 5 years) | +11.00% |
| Revenue growth (last year) | -44.28% |
| P/E ratio | NM |
| Price/Sales | 58.51 |
| Price/Book | 4.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ARCTArcturus Therapeutic... | -9.76 | -16.57% |
| ---- | ||
| ZEALZealand Pharma A/S | 0.00 | 0.00% |
| INVAInnoviva Inc | +0.02 | +0.11% |
Data as of 4:00pm ET, 08/11/2020
Financials
| Next reporting date | November 10, 2020 |
| EPS forecast (this quarter) | -$0.93 |
| Annual revenue (last year) | $29.5M |
| Annual profit (last year) | -$145.4M |
| Net profit margin | -492.27% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Vancouver, British Columbia |
Forecasts
